Delivery Order SPE2DB24D1205-SPE2DB25FCTFW

Award Date 1/22/25
Potential Completion Date 2/12/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,662.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award is a delivery order with a firm fixed price of $10,641.07 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product, with a period of performance through March 20, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, valued at $10,662.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product, with a completion date of April 30, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $10,662.57, is for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with a total potential value of $999,999,999 that runs through November 2026. The IDC serves as a primary vehicle...
This federal contract award, valued at $10,641.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product, with a period of performance through April 30, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $21,806.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that covers the supply of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product, on a firm fixed-price basis. The contract has an ultimate completion date of January 9, 2025. This award is not designated as a set-aside contract. The contract appears to be part of a...
This federal contract award, valued at $10,871.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of December 17, 2024. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a for-profit organization and a registered vendor in the System for...
This federal contract award, valued at $10,247.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award, valued at $21,325.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product, with a completion date of January 29, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $10,508.31, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product, with a completion date of June 11, 2024. The contract is a Delivery Order and is a Firm Fixed Price type. This award is associated with a larger Indefinite Delivery...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCTFW
    Delivery Order

This federal contract award, valued at $10,662.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a medical product, with a completion date of February 12, 2025.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The awarded contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and no subcontractors are mentioned. The contract type is Firm Fixed Price, and the pricing type is Firm Fixed Price.

Generated 4/23/25, 12:44 PM